Risk factors for ocular chlamydia after three mass azithromycin distributions.

Ayele, Berhan; Gebre, Teshome; Moncada, Jeanne; House, Jenafir I; Stoller, Nicole E; Zhou, Zhaoxia; Porco, Travis C; Gaynor, Bruce D; Emerson, Paul M; Schachter, Julius; Keenan, Jeremy D

Ayele, Berhan; Gebre, Teshome; Moncada, Jeanne; House, Jenafir I; Stoller, Nicole E; Zhou, Zhaoxia; Porco, Travis C; Gaynor, Bruce D; Emerson, Paul M; Schachter, Julius; Keenan, Jeremy D.

Affiliation

Ayele B; The Carter Center, Addis Ababa, Ethiopia.

PLoS Negl Trop Dis ; 5(12): e1441, 2011 Dec.

Article in En | MEDLINE | ID: mdl-22180804

Subject(s)

Anti-Bacterial Agents/administration & dosage; Azithromycin/administration & dosage; Trachoma/drug therapy; Trachoma/epidemiology; Child; Child, Preschool; Chlamydia trachomatis/genetics; Chlamydia trachomatis/isolation & purification; Cross-Sectional Studies; DNA, Bacterial/analysis; Ethiopia/epidemiology; Family Characteristics; Female; Humans; Logistic Models; Male; Odds Ratio; RNA, Bacterial/analysis; Risk Factors; Socioeconomic Factors; Travel

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Trachoma / Azithromycin / Anti-Bacterial Agents Type of study: Clinical_trials / Etiology_studies / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Limits: Child / Child, preschool / Female / Humans / Male Country/Region as subject: Africa Language: En Year: 2011 Type: Article

Fulltext

XML

PubMed Links

Search on Google